Cargando…
New onset of myasthenia gravis after intravesical Bacillus Calmette-Guerin: A case report and literature review
RATIONALE: Recently, drug-related myasthenia gravis (MG) has received attention, because the number of reported cases involving MG associated with immune checkpoint inhibitors, a new immunotherapy, is increasing. We present a case involving the new onset of MG, in which the symptoms started shortly...
Autores principales: | Takizawa, Tsubasa, Kojima, Marenori, Suzuki, Shigeaki, Osada, Takashi, Kitagawa, Satoshi, Nakahara, Jin, Takahashi, Shinichi, Suzuki, Norihiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704874/ https://www.ncbi.nlm.nih.gov/pubmed/29145329 http://dx.doi.org/10.1097/MD.0000000000008757 |
Ejemplares similares
-
Anemia in female patients with myasthenia gravis
por: Sekiguchi, Koji, et al.
Publicado: (2022) -
Flare of myasthenia gravis induced by COVID-19 vaccines
por: Ishizuchi, Kei, et al.
Publicado: (2022) -
Managing the adverse events of intravesical bacillus Calmette–Guérin therapy
por: Decaestecker, Karel, et al.
Publicado: (2015) -
Tuberculous Spondylitis Caused by Intravesical Bacillus Calmette-Guerin Therapy
por: Minakata, Tomokazu, et al.
Publicado: (2020) -
Reactive Arthritis After Intravesical Bacillus Calmette-Guérin Therapy
por: Taniguchi, Yoshinori, et al.
Publicado: (2022)